Coronavirus (COVID-19) Update - We are open with your safety in mind.
Click here to learn more.
The objective of this Phase 3 study is to evaluate the efficacy of lasmiditan 200 mg and 100 mg on migraine headache pain freedom compared to placebo.
Eli Lilly and Company
Amanda Tinsley, MD